Skip to main content
Premium Trial:

Request an Annual Quote

Thanks to Today's PIs: Dec 2, 2007

Premium

Genome Technology extends its sincere thanks to the leaders who generously took the time to recommend the up-and-coming investigators profiled in this special issue. We’re delighted to have such a noteworthy group of scientists to point us in the right direction.

Russ Altman
Stanford University

David Baker
University of Washington

Ewan Birney
European Bioinformatics Institute

Roger Brent
Molecular Sciences Institute

Steven Briggs
University of California, San Diego

Margit Burmeister
University of Michigan

Aravinda Chakravarti
Johns Hopkins University School of Medicine

George Church
Harvard Medical School

David Clemmer
Indiana University

Francis Collins
National Human Genome Research Institute

Richard Gibbs
Baylor College of Medicine

Jonathan Haines
Vanderbilt University

Lee Hartwell
Fred Hutchinson Cancer Research Center

David Haussler
University of California, Santa Cruz

Laurence Kedes
Keck School of Medicine, University of Southern California

Chittaranjan Kole
Clemson University

Elaine Mardis
Washington University
School of Medicine

Jill Mesirov
Broad Institute

Joachim Messing
Rutgers University

Paul Morrison
Dana-Farber Cancer Institute

Emanuel Petricoin
George Mason University

John Quackenbush
Dana-Farber Cancer Institute

Steve Scherer
Hospital for Sick Children

Barbara Sherry
North Carolina State University

Michael Snyder
Yale University

Bruce Stillman
Cold Spring Harbor Laboratory

Greg Tsongalis
Dartmouth-Hitchcock Medical Center

Juan Valcárcel
Centre de Regulació Genòmica

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more